Analyst Profile

Robert LeBoyer

Robert LeBoyer

Senior Life Sciences Analyst

noble

tipranks

Bio

Robert LeBoyer joined Noble Capital Markets in 2021 to cover the Biotechnology and Specialty Pharmaceuticals industry. Mr. LeBoyer began his research career at Prudential Securities, and has previously been a Senior Biotechnology Analyst at Brown Brothers Harriman and Leerink Swann, joining Noble from Ladenburg Thalmann. Robert holds a BA in Economics from Tulane University and an MBA from Columbia Business School.

Credentials

Senior Equity Research Analyst focusing on the Biotechnology and Specialty Pharmaceuticals industry. 16 years of industry experience. BA in Economics from Tulane University and an MBA from Columbia Business School.

FINRA licenses 7, 24, 63, 86, 87

Coverage List

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.